NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news  1  2  3  4  5  » 
found files: 758
»17/02/2007 [Industry news]
Italy Signs Agreement for Joint TCM Lab in China

The Chinese Ministry of Science and Technology's Vice Minister Shang Yong and visiting Italian Health Minister Livia Turco have signed an MOU on building a joint lab for integrating TCM with modern systematic biology and modern biotechnologies....   more»

»04/03/2007 [Industry news]
China Blood Collection Centres contribute to spread of HIV

In parts of China,blood donors are not screened, increasing risk of diseases spreading. This is due to safety procedures being ignored by officials with financial interest in blood supply. In 2004 Gvmt shut down 150 illegal centres/agencies...   more»

»04/03/2007 [Industry news]
Chinese Drug Safety under Spotlight

In 2006 China approved 6500 new drugs - the US approved approx. 100. Accidents and even deaths from disqualified drugs has created political interest in China who are calling for stiffer punishments and better safety procedures....   more»

NCCSED »06/03/2007 [Industry news]
Frontier links with NCCSED (CRO) in China

US based Frontier Biosciences has signed agreement with National Chengdu Centre for Safety Evaluation of Drugs - a full service pre-clinical CRO regarded as one of the best in China - established by West China Hospital of the Sichuan University...   more»

»27/03/2007 [Industry news]
China Medical Technologies and Biomed-X Center will establish a new research laboratory

China Medical Technologies Inc. has entered into a 10-year collaboration agreement with the Biomed-X Center of Peking University to establish a new research laboratory that is expected to be used as a platform for the research and development of medical devices that complement China Medical's existing products....   more»

»29/03/2007 [Industry news]
SFDA approves three GLP centres

SFDA has approved three GLP centres. They are: 1. Hubei Center For Disease Control And Prevention—Institute Of Food And Drug Safety Evaluation (Hubei province ,China) 2. Chinese Academy Of Medical Sciences & Peking Union Medical College--Institute Of Laboratory Animal Science (Beijing, China): This GLP center has approved AAALAC. 3. Tianjin Institute Of Pharmaceutical Research—New Drug Safety Evaluation Center (Tianjin, China)...   more»

»10/04/2007 [Industry news]
Former SFDA Head accused of taking 5Million Yuan bribe

Zheng Xiaoyu, former director of the State Food and Drug Administration (SFDA), who was expelled from the Communist Party of China (CPC) last month, has been accused of taking bribes of more than 5 million yuan (about 650,000 U.S. dollars)....   more»

»07/04/2007 [Industry news]
China's drug watchdog sends supervisors to blood, vaccine pharmaceutical producers

China's drug watchdog has sent supervisors to firms producing blood-based drugs and vaccines across China to crack down on the production of fake drugs. More than 80 supervisors from the State Food and Drug Administration (SFDA) had been sent to 33 blood-based drug producers and 31 vaccine producers in 24 provinces, autonomous regions and municipalities by the end of March....   more»

Wuxi Pharma Tech »07/04/2007 [Industry news]
WuXi PharmaTech Sets Up Life Science and Chemistry Award

WuXi PharmaTech, China's leading provider of pharmaceutical outsourcing services is pleased to announce the establishment of the "WuXi PharmaTech Life Science and Chemistry Award"; worth one million RMB. The award will honor individuals and groups who make a significant contribution to the fields of life science and chemistry in China....   more»

»28/04/2007 [Industry news]
US-based Agilent Technologies plans to more than double its R&D workforce in China

US-based Agilent Technologies, the world's largest maker of scientific-testing gear, plans to more than double its research and development (R&D) workforce in China and have 1,000 R&D engineers here. Agilent now employs 1,300 people in China, including 400 R&D engineers. "China is now our second-largest and fastest-growing market in the world," Sullivan said. "We hope to grow faster than the market and remain the No 1 measuring company."...   more»

»17/04/2007 [Industry news]
Bridgetech \Holdings sponsor Beijing conference

Bridgetech Holdings International, Inc., a company focused on maximizing the potential of emerging healthcare products and services in the US and Asian markets, announced today that it has agreed to be the anchor sponsor for the 2007 Asia-Pacific Conference of Tumor Biology and Medicine, a major international event hosted annually by the Chinese Anti-Cancer Association (CACA). This year's conference will be held at Beijing's 301 Hospital from 15-17 September 2007. A NETWORKING OPPORTUNITY...   more»

»11/04/2007 [Industry news]
ATMI LifeSciences and Austar have created a joint venture, ATMI Austar LifeSciences, Ltd

ATMI LifeSciences and Austar have created a joint venture, ATMI Austar LifeSciences, Ltd., to produce and market high-end, ultra-clean sterile materials packaging for the pharmaceutical industry in the Asia-Pacific region. "This joint venture provides ATMI LifeSciences access to the active pharmaceutical ingredient and biopharmaceutical markets in Asia as well production capacity in addition to our Belgian operation," said Mario Philips, Managing Director of ATMI LifeSciences....   more»

»11/03/2007 [Industry news]
Aida Pharmaceuticals, Inc. has initiated pre clinical research of anti cancer treatment

Vasostatin-Apo2L is a recombinant fusion protein with the potential to inhibit tumor growth. The treatment may integrate the function of an extracted fragment of Vasostatin, an inhibitor of angiogenesis and tumor growth with similar results of Rh-Apo2L, the Company's existing anti-cancer treatment currently in Phase II trials, which induces the apoptosis (cellular death) of cancer cells. Scientists from Shanghai Qiaer Biotechnology are researching the potential incorporation of both treatments, Vasostatin-Apo2L and Rh-Apo2L, to increase the overall efficacy of cancer treatment....   more»

»30/04/2007 [Industry news]
USTR Toughens IP Stance On China, Russia, Thailand; Praises EU, Brazil

The United States Trade Representative’s office on 30 April announced the elevation of its pressure on China, Russia, Thailand, and others to better protect US intellectual property rights. But the announcement stirred reactions by accentuating the increasingly political-sounding criticism by developed countries of Thailand’s decision to utilise flexibilities under international trade rules allowing countries to manufacture cheap versions of patented drugs....   more»

»05/04/2007 [Industry news]
SFDA Newsletter of March

SFDA clarified the explanation of “The Illegal Gains” in Drug Administration Law and Regulations for the implementation of the Drug Administration Law.(16 Feb.2007) SFDA has been trying out sending inspectors to the drug manufacturers.(25 Feb.2007) The State Food and Drug Administration revised the “Warning” and “Notes” contents in the insert sheet of Ceftriaxone Sodium.(26 Feb.2007) The National Development and Reform Commission (NDRC) takes six measures to strengthen the medical price administration (3 Mar. 2007) SFDA solicits opinions on Provisions for Drug Registration(Draft for comment)(12 Mar. 2007) Investigation workshop for the obtaining availability of the essential drugs was held Jinan City of Shandong Province.(12 Mar. 2007)...   more»

»24/04/2007 [Industry news]
SinoBiomed's Malaria Vaccine Granted US Patent

SinoBiomed Inc. is pleased to announce that the United States Patent and Trademark office has granted a patent for the malaria vaccine PfCP2.9 to which SinoBiomed has exclusive rights to develop, manufacture and sell through its 82 percent owned subsidiary, Shanghai Wanxing Bio-pharmaceuticals Co. Ltd....   more»

»18/04/2007 [Industry news]
Nutra Pharma completes JV meetings with Nanogene

ReceptoPharm, the drug discovery division of Florida-based biotech firm, Nutra Pharma, has completed initial discussions with Zhong Xin Dong Tai Co. Ltd. (Nanogene Biotechnology) to develop RPI-MN for the Chinese market....   more»

»24/04/2007 [Industry news]
Carefx names Dr Qi Li as VP, Clinical Strategy

Scottsdale-based Carefx Corporation has appointed Dr Qi Li as Vice President of Clinical Strategies, a newly created position focused on evolving the company’s clinical workflow offerings and bridging the gap between evidence-based medicine and information technology for the providers in healthcare organizations....   more»

»02/05/2007 [Industry news]
Chinese pharma sales to exceed $46 billion by 2010

Bangalore, May 2, 2007: Market research firm Research and Markets, in its recently published report, China Pharmaceuticals and Healthcare Report Q4 2006, indicates that China is a burgeoning market....   more»

»11/05/2007 [Industry news]
Biotech industry's first five-year plan

The Council Office has announced its first five-year plan on biotech industry. The aim is to achieve a goal of 500 billion yuan (US$65 billion) in 2010, and 2 trillion yuan by 2020. In the five-year plan of the biotech industry, the focus area will be biomedicine, bio-agriculture, bio-energy and bio-manufacturing, according to the Shanghai Securities News.. To reach this high goals, the plan has four detailed objectives. The first is to initially form a supporting system to help developthe biotech industry. The second is to enhance innovation. The next objective is to optimize and upgrade the industry¡¯s structure. And finallyto expand the the biotech industry output....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.